Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Barris Peter J
Relationship:   Director
City:   Baltimore
State:   MD
   
Insider Summary:
  
   
Companies Owned :   61    
Direct Shares   374,379    

Indirect Shares

   283,825,989      
Direct Value   $4,125,326    

Indirect Value

   $1,346,317,471      
Total Shares   284,200,368      
Total Value   $1,350,442,798      


Vonage Holdings Corp $2,553,224 Innerworkings Inc $106,292 Inteliquent Inc $0 Groupon, Inc. $34,213 Senseonics Holdings Inc $23,700 Sprout Social, Inc. $495,729 Nextnav Inc. $442,217 Zerofox Holdings Ord Shs $469,952 Vonage Holdings Corp $2,553,224 Innerworkings Inc $106,292 Inteliquent Inc $0 Groupon, Inc. $34,213 Senseonics Holdings Inc $23,700 Sprout Social, Inc. $495,729 Nextnav Inc. $442,217 Zerofox Holdings Ord Shs $469,952
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    4    

     Stock price went up :
    0   
    2    
     Stock price went down :
    0   
    2    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
 -37.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Welltek Incorporated WTKND Former 10% Owner 0 2004-09-28 14,470    Premium*  
            Aradigm Corp ARDM 10% Owner 2003-12-11 0 2004-02-20 0    Premium*  
            FoxHollow Technologies FOXH Former 10% Owner 2004-11-02 0 2004-11-02 1,804,462    Premium*  
            DZS Inc DZSI 10% Owner 2005-02-10 0 2008-03-10 12,051,646    Premium*  
            Occam Networks Inc OCNW 10% Owner 2006-04-06 0 2006-04-07 0    Premium*  
            Gyre Therapeutics GYRE 10% Owner 2006-04-12 0 2013-12-05 4,563,512    Premium*  
            Paratek Pharmaceuticals Inc PRTK 10% Owner 2006-05-15 0 2009-01-30 2,083,426    Premium*  
            Vonage Holdings Corp VG Director 2012-07-01 121,640 2012-07-01 11,752,903    Premium*  
            Innerworkings Inc INWK Director 2012-05-30 35,549 2012-05-30 4,529,190    Premium*  
            Amicus Therapeutics Inc FOLD 10% Owner 2007-06-05 0 2007-07-25 4,510,340    Premium*  
            Inteliquent Inc IQNT Director 2011-11-16 27,126 2009-06-10 0    Premium*  
            Echo Global Logistics Inc ECHO Director 0 2012-03-05 0    Premium*  
            Financial Engines, Inc. FNGN 10% Owner 0 2010-08-30 3,481,941    Premium*  
            Groupon, Inc. GRPN Director 2022-06-15 24,614 2022-06-15 39,933    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 2,483    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO 10% Owner 2012-07-03 0 2019-01-22 0    Premium*  
            Hyperion Therapeutics Inc HPTX 10% Owner 0 2015-05-07 0    Premium*  
            Audience Inc ADNC 10% Owner 2013-02-15 0 2013-11-05 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-10 117    Premium*  
            Tableau Software Inc DATA 10% Owner 2013-05-22 0 2014-12-02 69,572    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2013-06-05 0 2016-01-12 6,261,599    Premium*  
            Boingo Wireless Inc WIFI 10% Owner 2013-08-21 0 2013-12-11 0    Premium*  
            Glycomimetics Inc GLYC 10% Owner 0 2018-05-10 9,089,041    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 290    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Viracta Therapeutics Ord Shs VIRX 10% Owner 2014-08-08 0 2014-08-29 4,659,333    Premium*  
            Ardelyx Inc ARDX 10% Owner 2014-12-23 0 2019-12-09 6,564,816    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Supernus Pharmaceuticals Inc SUPN 10% Owner 2015-06-15 0 2015-11-11 212,650    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Vitae Pharmaceuticals, Inc VTAE 10% Owner 2015-07-01 0 2015-07-01 1,171    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Xtera Communications, Inc. XCOM 10% Owner 0 2015-11-17 971,733    Premium*  
            Adaptimmune Therapeutics PLC ADAP 10% Owner 0 2018-09-07 12,000,000    Premium*  
            Senseonics Holdings Inc SENS 10% Owner 2017-12-08 48,377 2017-12-08 30,888,266    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2019-04-08 25,243,865    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN 10% Owner 2017-07-03 0 2017-07-03 8,140,138    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2019-05-07 2,052,454    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2017-11-20 0 2018-02-13 1,167    Premium*  
            Liquidia Technologies Inc LQDA 10% Owner 2018-07-30 0 2018-07-30 2,484,870    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2019-06-24 7,225,676    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2019-05-09 4,438,562    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Oyster Point Pharma, Inc. OYST 10% Owner 0 2019-10-30 322,458    Premium*  
            Sprout Social, Inc. SPT Director 2023-05-22 16,873 2023-05-22 99,246    Premium*  
            Revolution Acceleration Acquisit... BGRY 2023-07-20 0 2021-09-27 0    Premium*  
            Nextnav Inc. NN Director 2022-06-22 57,282 2021-12-27 0    Premium*  
            Zerofox Holdings Ord Shs ZFOX Director 2022-12-14 42,918 2022-12-14 0    Premium*  
* Premium Members only  

Records found :    483         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 11 of 20
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
DZSI DZS Inc 10% Owner   –       –       •   2007-11-13 4 B $1.25 $14,200 I/I 11,360 7,497,463 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2005-03-14 4/A B $2.45 $15,925 I/I 6,500 3,838,912 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2005-03-14 4 B $2.45 $15,925 I/I 6,500 3,838,822 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-08-21 4 B $1.20 $17,760 I/I 14,800 7,153,285 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-12-03 4 B $1.25 $17,925 I/I 14,340 7,817,736 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-11-09 4 B $1.24 $19,142 I/I 15,384 7,481,456 1.5 -
DZSI DZS Inc Former 10% Owner   –       –      –    2005-11-04 4 B $2.41 $22,042 I/I 9,163 5,142,088 0.01 -
ARDM Aradigm Corp 10% Owner   –       –       •   2004-02-20 4 S $2.35 $24,091 I/I (10,247) 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-11-05 4 S $9.83 $25,288 I/I (2,573) 0 0 -
DZSI DZS Inc 10% Owner   –       –       •   2007-11-12 4 B $1.25 $25,749 I/I 20,654 7,491,783 1.5 -
GYRE Gyre Therapeutics 10% Owner   –       –       •   2013-11-21 4 S $5.16 $27,533 I/I (5,333) 1,000 0 -
DZSI DZS Inc 10% Owner   –       –       •   2008-02-26 4 B $1.12 $28,343 I/I 25,205 8,488,982 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-08-20 4 B $1.20 $28,990 I/I 24,158 7,145,885 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-08-22 4 B $1.20 $30,000 I/I 25,000 7,165,785 1.5 -
HPTX Hyperion Therapeutics Inc 10% Owner   –       –       •   2014-06-06 4 S $26.90 $30,506 I/I (1,134) 0 0 -
SENS Senseonics Holdings Inc 10% Owner   –       –       •   2017-12-07 4 S $2.61 $31,628 I/I (12,100) 32,850 0 -
INWK Innerworkings Inc Director   –       •      –    2012-05-30 4 S $11.65 $34,868 I/I (2,993) 0 0 -
ADNC Audience Inc 10% Owner   –       –       •   2013-03-07 4 S $12.96 $36,187 I/I (2,792) 0 0 -
DZSI DZS Inc 10% Owner   –       –       •   2007-09-13 4 B $1.20 $36,863 I/I 30,719 7,472,416 1.5 -
ECHO Echo Global Logistics Inc Director   –       •      –    2012-03-05 4 S $17.98 $41,019 I/I (2,281) 0 0 -
ARDX Ardelyx Inc 10% Owner   –       –       •   2014-12-26 4 S $21.28 $41,961 I/I (1,972) 0 0 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-05-18 4 B $2.14 $42,928 I/I 20,100 17,558,822 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-08-23 4 B $1.20 $43,265 I/I 36,054 7,183,812 1.5 -
DZSI DZS Inc 10% Owner   –       –       •   2007-11-14 4 B $1.25 $44,905 I/I 35,924 7,515,425 1.5 -
AVEO Aveo Pharmaceuticals Inc 10% Owner   –       –       •   2018-11-28 4 B $1.99 $48,824 I/I 24,500 20,092,538 1.5 -
  483  Records found
  1   2   3   4   5   6   7   8   9   10   11  12   13   14   15   16   17   18   19   20      
  Page 11 of 20  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us